Carvolix secures new €10 million financing tranche

Evidence notes

• The reserved offering issues 2,976,190 new ordinary shares at €3.36 per share to existing shareholders.
• Carvolix says proceeds support Tavipilot commercialization in the United States and development of Tavipilot, Kalios, Artus, Artedrone and Mitrapilot.
• The tranche extends the company’s cash runway to the end of September 2026, with venture debt under negotiation.